Skip to main content

Using mass cytometry to identify clinically relevant biological signatures in human health and disease



Mass cytometry has emerged in recent years as a powerful tool for single-cell analysis in both basic and clinical research studies.

This virtual seminar from our Corporate Member, Fluidigm, features two speakers discussing mass cytometry technology and its application in human immunology and disease research. This seminar will take place on Tuesday 4 May from 16:00 to 17:00 BST.

Fluidigm is pleased to welcome Dr Brice Gaudilliere of the Stanford School of Medicine, to discuss how his group applies mass cytometry and other proteomic technologies to obtain multi-omic views of several clinical scenarios, including:

  • Immune mechanisms of surgical recovery and complications
  • Pregnancy and preterm birth
  • Immune dysfunction and outcomes prediction in patients with COVID-19